Skip to main content
Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.61
-0.70 (-4.89%)
At close: Nov 13, 2026, 4:00 PM EST
13.68
+0.07 (0.51%)
After-hours: Nov 13, 2026, 7:30 PM EST

Korro Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.296.392.27---
Revenue Growth
-82.47%181.46%----
Cost of Revenue
42.355.1352.3148--
Gross Profit
-41.01-48.74-50.04-48--
Selling, General & Admin
35.1138.641.8736.5421.3914.06
Research & Development
----37.6121.43
Operating Expenses
35.1138.641.8736.545935.49
Operating Income
-76.12-87.34-91.91-84.53-59-35.49
Other Non Operating Income (Expenses)
5.235.238.473.390.9813.54
EBT Excluding Unusual Items
-71.75-82.11-83.44-81.15-58.02-21.96
Merger & Restructuring Charges
-2.39-3.63----
Asset Writedown
-30.89-30.89----
Pretax Income
-105.03-116.62-83.44-81.15-58.02-21.96
Income Tax Expense
1.10.640.140.030.010
Net Income
-106.13-117.26-83.58-81.17-58.03-21.96
Net Income to Common
-106.13-117.26-83.58-81.17-58.03-21.96
Net Income Growth
------
Shares Outstanding (Basic)
1499204
Shares Outstanding (Diluted)
1499204
Shares Change
50.71%5.32%483.30%499.32%-94.26%-
EPS (Basic)
-7.50-12.48-9.37-53.08-227.42-4.94
EPS (Diluted)
-7.50-12.48-9.37-53.08-227.42-4.94
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-63.87-79.08-77.98-75.12-58.86-36.54
Free Cash Flow Per Share
-4.52-8.42-8.74-49.12-230.65-8.22
Operating Margin
-5891.49%-1366.43%-4047.12%---
Profit Margin
-8214.47%-1834.48%-3680.36%---
Free Cash Flow Margin
-4943.81%-1237.16%-3433.55%---
EBITDA
-74.37-83.06-88.35-80.9-56.49-33.9
D&A For EBITDA
1.754.283.573.632.511.6
EBIT
-76.12-87.34-91.91-84.53-59-35.49
SEC Filings: 10-K · 10-Q